MS. SUCHI is an experienced International Pre School Principal/Manager who picked up Laughter exercises from many coaches around the world. She then designed ‘Laughter Therapy' which is being used in many places such as hospitals and Senior Activity Centres. She provides individual and group therapy in educational and home settings.

A former Manager / Trainer is now engages in building social awareness about Holistic approach for recovery. Be it Depression, Anxiety caused by physical or emotional pain, Death in the family and the harm the unhappiness brings to people, families and communities. Her aim is to encourage people to seek help early and get on the path to recovery. Her works has been featured in local press, TV and Radio and has been an invited speaker at various community clubs and educational Institutions. She has also been awarded by MINDS and various community clubs in recognition of her social work.

Dr. Jerry Katzman is the Company’s Chief Executive Officer, President, and Chairman of the Board of Directors. Dr. Katzman has always been an entrepreneur, scientist, and pioneer in medical science. His focus has targeted various biotechnology companies, biopharma, and Wall Street. Upon completion of his medical training, Dr. Katzman joined a multi-specialty group practice in Brandon, FL where he founded and established the group’s department of ophthalmology.

In 2013, founded Disruptor Technologies Inc., a marketing and consulting company, and served as the CEO. Disruptor was developed to research, identify, evaluate, obtain, develop, promote, manufacture, and/or market groundbreaking technologies in health and science.

ophthalmologist in Detroit, Michigan, Pine Bluff, and other many institutes.

Eye Specialist

Dr. Herbert Gould is an ophthalmologist in Gaithersburg, Maryland and is affiliated with Adventist Healthcare Shady Grove Medical Center. He received his medical degree from NYU School of Medicine and has been in practice for more than 20 years.

Ophthamologists diagnose and treat eye diseases, including vision loss, detached retinas, cataracts and glaucoma. They perform laser retina surgery, refractive surgery and lens replacement operations.

Professor Université Clermont Auvergne Clermont-Ferrand, France

cataract sugery

Ophthalmologist specialist Anterior Segment Surgeries Specialist. Hospital Santa Lucía. Buenos Aires.

surgery Cataratas

Dr. Tekleweyn is the fellowship trained Doctor of Medicine in the Ethiopia when he established practice inEthiopia-1993's as a specialist in Medicine and external eye disease.

Pulmonary & Critical Care

Equipe de Biophysique Neurosensorielle, UMR INSERM 1107 Service de Biophysique, Mathématiques et informatique Pharmaceutiques

Faculté de Pharmacie TSA 50400 28 Place Henri Dunant 63001 CLERMONT-FERRAND, Cedex1

Naj Sharif is a graduate of Southampton University, England (UK), where he received his BSc in Biochemistry and Physiology and his PhD in Neuroscience. He has been in the pharmaceutical industry for 31-years holding leadership positions of increasing scope and responsibility, spanning discovery research, drug development and regulatory affairs. His 22-year R&D tenure at Alcon resulted in his contributions to the discovery/development and US FDA and EMA approvals of Travatan® (Travoprost), Simbrinza®, Patanol® (Olopatadine) and Emedine® (Emedastine), to treat glaucoma/ocular hypertension and ocular allergies. He has also discovered, patented and out-licensed the first FP-prostaglandin-receptor antagonist (AL-8810) that is proving a useful pharmacological tool to dissect the role of FP-receptors in human and animal diseases. He is an Associate Editor of J. Ocular Pharmacology & Therapeutics, and an Editorial Board Member of Molecular Vision, Current Eye Research and European Journal of Pharmacology. He is an Adjunct Professor at several universities and a Thesis Advisor for MS- and PhD graduate students. He has published >190 scientific articles and edited 2 Neuroscience books. He is the Inventor of 22 issued US and EU patents (+ 20 pending patent applications) on ocular cell-lines and small novel molecules to treat human diseases of the CNS and the eye.

Glaucoma treatment: Novel drugs and devices on the horizon

Dr. Aquavella was the first fellowship trained corneal surgeon in the United States when he established practice in Rochester in the mid-1960's as a specialist in cornea and external eye disease. He continues to be a leader in clinical practice, surgery, education and research.

corneal surgeon

Prof. Hafezi’s primary focus is medical and refractive corneal surgery, particularly the management of refractive laser surgery complications and the treatment of corneal ectatic disorders. He was also instrumental in the clinical development and international establishment of corneal cross-linking (CXL) for the treatment of keratoconus. In 2010, Prof. Hafezi was appointed to the University of Geneva, where he headed the Ophthalmic Clinic until 2014 as Senior Physician and Full Professor. Hafezi holds an adjunct professorship in Los Angeles at the Keck School of Medicine at the University of Southern California (USC) since 2012, and in 2015, he started as Medical Director of the ELZA Institute in Dietikon and as Group Leader of the Ocular Cell Biology research group the Centre for Applied Biotechnology and Molecular Medicine at the University of Zurich. In 2017, Prof. Hafezi was made a Visiting Professor in the Faculty of Medicine at Wenzhou Medical University, Wenzhou, China.

Clinical activity

Professor Ghanchi initiated his cataract surgery in 1986, refining surgical techniques to modern small incision phacoemulsification and has trained many eye surgeons.He provides patient-centred cataract surgery, usually under topical drops or local anaesthetic.

Clinical interests

Dr. Hugo Quiroz-Mercado is an ophthalmologist specialized in diseases of the retina, macular diseases, diabetic retinopathy, and retinopathy prematurity. He is currently Retinal surgeon with an appointment at Hospital para Evitar la Ceguera en México, I.A.P., and Medica Sur Hospital. He holds his appointment as a professor at the University of Colorado, Denver. With over 25 years of practice experience, Dr. Quiroz has held previous appointments as the Director of the Retina Department and Chief of the Experimental Surgery Laboratory at Luis Sanchez Hospital for the Prevention of Blindness, as well as a professor of Ophthalmology at the Facultad de Medicina, Universidad Autonoma de Mexico. He specializes in treating patients with severe retinopathy and helping them cope with the impending complications. Dr. Quiroz is the former Director of Ophthalmology at Denver Health Medical Center where he influenced teaching programs mainly in Vitreoretinal Surgery as well as impulse research in different areas of Ophthalmology. urrently, he is director of Research at Asociación para Evitar la Ceguera en México acting as the liaison between several Ophthalmological programs at the USA such are: University of Colorado, Stanford University and Allegro Ophthalmics from Irvine CA. He is a Research level III at Conacyt (Consejo Nacional de Ciencia y Tecnología).

Retina, Macular diseases, Diabetic retinopathy, and Retinopathy prematurity

Elias F Jarade, MD. is the director of the Corneal, External Disease, and Refractive Surgery Services at Beirut Eye Specialist Hospital. Dr. Elias is a graduate of Harvard Medical School with 2 certificates of fellowship in cornea and refractive surgery from the Eye Center and Eye Foundation for Research, and The Massachusetts Eye and Ear Infirmary, Harvard Medical School. Dr. Elias is heavily involved in the practice and research of cornea, cataract, refractive surgery for the past 15 years with main interest in keratoconus. Has to his record more than 50 peer reviewed scientific papers and chapters. Also, presenter and invited faculty in the field of cornea and refractive surgery at international meetings. Board member for the “Journal of Refractive Surgery” “International Journal of Ophthalmology”, “International Advisory Board for the Saudi Journal of Ophthalmology”, Founder-general secretary of the Emirates Cornea and Refractive Surgery (ECRS) club, Guest editor for the “Journal of Ophthalmology”.

Pediatric Ophthalmology

asads

asadasd